Home/Filings/4/0001209191-10-008925
4//SEC Filing

Ruppel Edward F Jr 4

Accession 0001209191-10-008925

CIK 0001028318other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 3:45 PM ET

Size

13.7 KB

Accession

0001209191-10-008925

Insider Transaction Report

Form 4
Period: 2010-02-11
Ruppel Edward F Jr
Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2010-02-11$1.15/sh+12,736$14,61515,672 total
  • Sale

    Common Stock

    2010-02-11$18.77/sh1,832$34,38713,840 total
  • Sale

    Common Stock

    2010-02-11$18.78/sh1,000$18,78012,840 total
  • Sale

    Common Stock

    2010-02-11$18.75/sh6,904$129,4505,936 total
  • Sale

    Common Stock

    2010-02-11$18.79/sh3,000$56,3702,936 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2010-02-11$1.15/sh12,736$14,6150 total
    Exercise: $1.15Exp: 2013-10-29Common Stock (12,736 underlying)
Footnotes (2)
  • [F1]This grant was initially reported on the reporting person's Form 3 report filed on June 15, 2005 and the exercise price was reflected at a rounded price of $1.15.
  • [F2]This grant is fully vested and exercisable. The original vesting schedule was as follows: 1/4 vested at the one year anniversary, 1/48th of entire amount vested each month thereafter.

Issuer

MICRUS ENDOVASCULAR CORP

CIK 0001028318

Entity typeother

Related Parties

1
  • filerCIK 0001325284

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 3:45 PM ET
Size
13.7 KB